BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 16858169)

  • 1. Terbinafine versus itraconazole and fluconazole in the treatment of Vulvovaginal candidiasis.
    Ferahbas A; Koc AN; Uksal U; Aygen E; Mistik S; Yildiz S
    Am J Ther; 2006; 13(4):332-6. PubMed ID: 16858169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of three different anti-fungus drugs on Candida albicans of murine vaginal mucosa.
    Chen S; Li S; Liu Z; Wu Y; Tu Y; Li J
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):209-12. PubMed ID: 17497300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of itraconazole and fluconazole therapy in vaginal candidosis].
    Vacheva-Dobrevski R; Kovachev S; Nacheva A; Stoev S; Vasilev N
    Akush Ginekol (Sofiia); 2004; 43(1):20-3. PubMed ID: 15168649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of in vitro itraconazole and fluconazole susceptibility with clinical outcome for patients with vulvovaginal candidiasis.
    Costa M; Passos XS; Miranda AT; de Araújo RS; Paula CR; Silva Mdo R
    Mycopathologia; 2004 Jan; 157(1):43-7. PubMed ID: 15008344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole vs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: a metaanalysis of randomized controlled trials.
    Pitsouni E; Iavazzo C; Falagas ME
    Am J Obstet Gynecol; 2008 Feb; 198(2):153-60. PubMed ID: 18068146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of itraconazole versus fluconazole in vaginal candidiasis.
    Akhtar S; Masood S; Tabassum S; Rizvi DA
    J Pak Med Assoc; 2012 Oct; 62(10):1049-52. PubMed ID: 23866445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
    Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
    Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terbinafine: a review of its use in onychomycosis in adults.
    Darkes MJ; Scott LJ; Goa KL
    Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK; Lynde CW; Konnikov N
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study on the effectiveness of antifungal agents in different regimens against vaginal candidiasis.
    Mikamo H; Kawazoe K; Sato Y; Hayasaki Y; Tamaya T
    Chemotherapy; 1998; 44(5):364-8. PubMed ID: 9732153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clotrimazole, fluconazole and itraconazole in vaginal candidiasis.
    Woolley PD; Higgins SP
    Br J Clin Pract; 1995; 49(2):65-6. PubMed ID: 7779645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of chronic vulvovaginal candidiasis: a long term retrospective study.
    Nguyen Y; Lee A; Fischer G
    Australas J Dermatol; 2017 Nov; 58(4):e188-e192. PubMed ID: 27250078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of fluconazole and clotrimazole for the treatment of vulvovaginal candidiasis.
    O-Prasertsawat P; Bourlert A
    Sex Transm Dis; 1995; 22(4):228-30. PubMed ID: 7482105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus.
    Tausch I; Decroix J; Gwiezdzinski Z; Urbanowski S; Baran E; Ziarkiewicz M; Levy G; Del Palacio A
    Int J Dermatol; 1998 Feb; 37(2):140-2. PubMed ID: 9542675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole.
    Wingfield AB; Fernandez-Obregon AC; Wignall FS; Greer DL
    Br J Dermatol; 2004 Jan; 150(1):119-26. PubMed ID: 14746625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.
    Singh S; Chandra U; Anchan VN; Verma P; Tilak R
    Br J Dermatol; 2020 Nov; 183(5):840-846. PubMed ID: 32538466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.